Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.

2.

More pain, more gain? New biopsy technique found to improve prostate cancer detection

3.

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

4.

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

5.

Gene therapies for BCG-unresponsive bladder cancer have high response rates.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot